Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Wealthfront Advisers LLC

Wealthfront Advisers LLC raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 3,876.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 25,049 shares of the biotechnology company’s stock after buying an additional 24,419 shares during the period. Wealthfront Advisers LLC’s holdings in Axon Enterprise were worth $14,887,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the company. Public Sector Pension Investment Board increased its holdings in Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after buying an additional 500 shares in the last quarter. CIBC Asset Management Inc boosted its position in Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after buying an additional 895 shares during the last quarter. Axxcess Wealth Management LLC bought a new position in Axon Enterprise during the 3rd quarter valued at $814,000. Soros Capital Management LLC bought a new position in shares of Axon Enterprise in the 3rd quarter worth about $630,000. Finally, Friedenthal Financial grew its stake in Axon Enterprise by 961.7% during the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after buying an additional 1,231 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Axon Enterprise

In other news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the sale, the director now directly owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Joshua Isner sold 1,291 shares of the stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total value of $829,377.13. Following the transaction, the president now directly owns 181,892 shares in the company, valued at approximately $116,852,877.56. This represents a 0.70 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 5,146 shares of company stock worth $3,262,847. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Trading Up 2.2 %

NASDAQ AXON opened at $526.64 on Wednesday. The stock has a market capitalization of $40.35 billion, a P/E ratio of 136.08, a P/E/G ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The firm has a 50-day moving average price of $596.28 and a 200 day moving average price of $532.72. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on AXON shares. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday. Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. Needham & Company LLC reissued a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. Finally, The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $587.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.